Work with Elpida BioPharm

Let’s move your
research forward.

From an early scientific question to a defined preclinical programme, we help you decide what to test, how to test it and what the results need to establish.

Biotechnology · Pharmaceuticals · Medical devices · Academic research

Choose a starting point
01 / CONTRACT RESEARCH

Plan a study or research programme

Study design, candidate comparison, efficacy, pharmacokinetics, safety or disease-model selection. Scope a focused experiment or a coordinated programme of work.

Discuss a CRO project →
02 / ACADEMIC COLLABORATION

Advance an academic project

Bring a research question, existing data or a manuscript in progress. Discuss experimental planning, interpretation, figures and writing, through submission and responses to reviewers.

Discuss research & publication support →
03 / DEVELOPMENT PARTNERSHIPS

Develop a programme together

Explore collaboration and co-development around our oncology and metabolic health programmes, or how our expertise could contribute to your own therapeutic development.

Discuss a programme partnership →

From first contact
to a clear plan.

We start with the scientific question, then define a practical scope of work and the evidence needed to move forward.

  1. 01 / SCIENTIFIC DISCUSSION

    Clarify the question

    Review the available evidence, identify the main gaps and agree on what the next study should help you decide.

  2. 02 / SCOPE & PROPOSAL

    Define the work

    Set out objectives, proposed models, endpoints, deliverables and milestones, together with the scope, budget and timeline.

  3. 03 / STUDY PREPARATION

    Prepare to begin

    Confirm materials, responsibilities, data requirements and the approvals needed for the agreed study, including ethics review where applicable.

A scientific team
behind the conversation.

Our founders bring experience in drug delivery, nanomedicine, experimental pharmacology, biomaterials and microbiome science. Their research connects biological mechanisms with preclinical evaluation.

Alexey Yaremenko

Alexey V. Yaremenko, PhD

CEO & Co-Founder

Nanomedicine, mRNA therapeutics and translational drug delivery. Principal Investigator of an H.F.R.I. (ELIDEK) project on lung cancer immunotherapy at Aristotle University of Thessaloniki.

Nadezhda Pechnikova

Nadezhda A. Pechnikova, MSc

CSO & Co-Founder

Experimental pharmacology, preclinical research and host–microbe interactions. FELASA-certified in laboratory animal science, with experience establishing a preclinical research facility.

Selected work by our founders in Nature Nanotechnology, Journal of Controlled Release and Gut Microbes. Read the research →

Interested in a programme partnership?

For MYCOCAN or our synbiotic programme, tell us which project interests you and the type of research, development or investment partnership you have in mind.

Start a partnership discussion